Showing 1 - 20 results of 58 for search '(( 5 y descrease ) OR ((((( _ mt decrease ) OR ( y de increase ))) OR ( _ late decrease ))))*', query time: 0.14s Refine Results
  1. 1

    Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice by Julie Decock (44558)

    Published 2015
    “…We have intercrossed Mmp8-null mice with the Polyoma virus middle T oncogene-driven (MMTV-PyMT) mouse model of mammary cancer to explore the effects of loss of MMP-8 on the incidence and progression of mammary carcinomas. …”
  2. 2
  3. 3

    Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose by Roberta Giordo (299595)

    Published 2021
    “…Treatment of HRECs with HG increased intracellular ROS levels and promoted phenotype shifting towards EndMT, evidenced by decreased expression of endothelial markers concomitant with increased expression of mesenchymal ones. …”
  4. 4
  5. 5

    The contribution of autophagy in glioblastoma multiforme cells treated with human recombinant arginase I-induced arginine deprivation. (c2018) by El Jbeily, Elie

    Published 2018
    “…Furthermore, the contribution of autophagy to arginine depletion-induced cytotoxicity in GBM cells was tested by incubating SF and U87 cells with either HuArgI (Co)-PEG5000 alone and in combination with an autophagy inhibitor (chloroquine or 3- methyladenine) at different time points. Cell death decreased when autophagy was inhibited in SF cells at late time points, thus proving its role in arginine depletion induced cell death. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  6. 6

    Recent advances in the treatment and outcome of locally advanced rectal cancer by Abdalla, Eddie

    Published 1999
    “…Objective To compare the outcomes of treatment of locally advanced rectal cancer of the early era (1975–1990) with those of the late era (1991–1997). Background Preoperative therapy has been used in locally advanced rectal cancer to preserve sphincter function, decrease local recurrence, and improve survival. …”
    Get full text
    Get full text
    article
  7. 7

    β-2-himachalen-6-ol protects against skin cancer development in vitro and in vivo by Daaboul, Hamid E.

    Published 2017
    “…Flow cytometry analysis revealed that treatment with 10 μg/ml HC significantly increased the number of cells undergoing late apoptosis (28%), while 25 μg/ml caused a larger cell shift towards late apoptosis (46.6%) and necrosis (39%). …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  8. 8
  9. 9

    Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways by Daaboul, Hamid E.

    Published 2017
    “…Flow cytometry analysis revealed that 10 μg/ml HC increased the number of cells undergoing necrosis (18.05%) and late apoptosis (15.66%). At HC 25 μg/ml more cells shifted toward necrosis (58.01%) and late apoptosis (30.47%). …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  10. 10

    The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer by El Mais, Nour

    Published 2020
    “…In this study, we hypothesized that HuArgI (Co)- PEG5000 can decrease the migration of ovarian cancer cells. Our results show a decrease in the migratory rate of the cells and their rate in wound closure. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  11. 11

    Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells by El-Sibai, Mirvat

    Published 2007
    “…Upstream of Arp2/3, Cdc42 knockdown inhibited EGF-stimulated activation of PI 3- kinase at early (within 1 minute) but not late (within 3 minutes) time points. Membrane targeting of N-WASP, WAVE2 and IRSp53 were also inhibited. …”
    Get full text
    Get full text
    Get full text
    article
  12. 12

    Aqueous urtica dioica leaves extract inhibits proliferation of acute myeloid leukemia cells in vitro by Rizk, Sandra

    Published 2017
    “…To confirm apoptosis, AnnexinV/PI dual staining method was performed showing a time- and dose-dependent increase in the number of cells in the early and late apoptosis stage. With respect to the proteins studied, treatment with Urtica dioica extract significantly increased the expression of the pro-apoptotic protein Bax with concomitant decrease in the anti-apoptotic protein Bcl-2 expression. …”
    Get full text
    Get full text
    Get full text
    article
  13. 13
  14. 14

    The chemotherapeutic effect of β-2-himachalen-6-ol in chemically induced skin tumorigenesis by Daaboul, Hamid E.

    Published 2018
    “…Papilloma yield, volume, histology, and mice weight and liver function were assessed. HC treatment decreased significantly cell survival (IC50 = 7 and IC90 = 40 μg/ml) and increased significantly cells undergoing late apoptosis and necrosis. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  15. 15

    Prehospital plasma transfusion versus standard of care following traumatic injury: a review of the systematic reviews and a meta-analysis by Ayman El-Menyar (440103)

    Published 2025
    “…PHP did not significantly decrease vasopressor use or late mortality; however, it may reduce the total use of RBCs in the first 24 h. …”
  16. 16

    Causes of Delay in Construction Projects in Oil and Gas Construction Industry by FANOUSSE, MARWA IMAD

    Published 2017
    “…With regard to design, the contractor’s need to decrease construction costs through a cheaper design was found to be a factor in design changes. …”
    Get full text
  17. 17
  18. 18

    Making Biomarkers Relevant to Healthcare Innovation and Precision Medicine by Nader I. Al-Dewik (14152884)

    Published 2022
    “…Many companies are now focusing on a translational medicinal approach as a therapeutic strategy in decision making upon realizing the expenses of drug attrition in late-stage advancement. In addition, the utility of biomarkers in clinical decision and therapy guidance seeks to improve the patient outcomes and decrease wasteful and harmful treatment. …”
  19. 19
  20. 20